Company news

Medicure Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Medicure Announces Intention to Commence Substantial Issuer Bid

November 4, 2019

Medicure Announces SMILE(TM)-HF Study Demonstrates Use of ReDS(TM) Results in 58% Reduction in Hospital Readmission Rate

October 15, 2019

Medicure Announces Preferred Pricing Agreement for Zypitamag(TM) with the AIDS Drug Assistance Program ("ADAP") Crisis Task Force

October 3, 2019

Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag(TM)

September 30, 2019

Medicure Announces Launch of New and Improved ReDS(TM) PRO

September 17, 2019

Medicure Reports Financial Results for Quarter Ended June 30, 2019

August 8, 2019

Medicure Q2 2019 Results and Conference Call Dates

August 2, 2019

Medicure Announces Results of 2019 Annual Meeting of Shareholders

June 26, 2019

Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer

June 10, 2019

Medicure Announces Renewal of its Normal Course Issuer Bid

May 30, 2019

Medicure Reports Financial Results for Quarter Ended March 31, 2019

May 27, 2019

Medicure Q1 2019 Results and Conference Call Dates

May 22, 2019

Medicure Appoints Ms. Manon Harvey to its Board of Directors

May 15, 2019

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018

April 29, 2019

Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019

April 24, 2019

Medicure Provides Update on Release of Holdback Funds from Apicore Sale

February 13, 2019

Medicure Announces Agreement to Market ReDS(TM) Device for Congestive Heart Failure Patients in the United States

January 28, 2019

Medicure reports financial results for quarter ended September 30, 2018

November 20, 2018

Medicure Q3 2018 Results and Conference Call Dates

November 14, 2018

Medicure Reports Financial Results for Quarter Ended June 30, 2018

August 15, 2018

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

August 13, 2018

Medicure Q2 2018 Results and Conference Call Dates

August 8, 2018

Medicure Reports Financial Results for Quarter Ended March 31, 2018

May 23, 2018

Medicure Q1 2018 Results and Conference Call Dates

May 17, 2018

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017

May 1, 2018

Medicure announces availability of ZYPITAMAG(TM) (pitavastatin) in the U.S.

May 1, 2018

Medicure to Announce Fiscal Year End 2017 Financial Results on April 30, 2018

April 24, 2018

Medicure Announces Further Up-Date on PREXXARTAN®

March 28, 2018

Medicure Announces an Up-Date on PREXXARTAN® Launch

March 19, 2018

Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.

March 7, 2018

Medicure Announces Receipt of Deferred Proceeds from Apicore Sale

February 1, 2018

Medicure Announces FDA Approval Received for Prexxartan®

December 19, 2017

Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.

December 14, 2017

Medicure Reports Financial Results for Quarter Ended September 30, 2017

November 21, 2017

Medicure Announces Repayment of Outstanding Debt

November 17, 2017

Medicure Q3 Results and Conference Call Dates

November 15, 2017

Medicure Acquires Exclusive License to Sell and Market PREXXARTAN® in the U.S. from Carmel Biosciences

October 31, 2017

Medicure Announces Sale of Apicore Business

October 3, 2017

Medicure Reports Financial Results for Quarter Ended June 30, 2017

August 7, 2017

Medicure Q2 Results and Conference Call Dates

August 2, 2017

Medicure Closes Acquisition of Additional Interests in Apicore

July 12, 2017

Medicure Exercises Option to Acquire Additional Interests in Apicore

July 10, 2017

Medicure Provides Update on Apicore Purchase Option

July 3, 2017

Medicure Reports Financial Results for Quarter Ended March 31, 2017

May 24, 2017

Medicure Q1 Results and Conference Call Dates

May 18, 2017

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016

April 26, 2017

Medicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017

March 29, 2017

Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine

March 23, 2017

Medicure Provides Apicore Secured Loan to Replace Knight Loan

January 9, 2017

Medicure announces filing of ANDA in collaboration with Apicore

December 13, 2016

← Newer news releases · Older news releases →

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 21 decks. Every deck is listed under its year.